Evidence map›Paper›PMID 25374433›Full record

ArticleDisease markers2014

Importance of follow-up cerebrospinal fluid analysis in cryptococcal meningoencephalitis.

Thomas Skripuletz, Philipp Schwenkenbecher, Kaweh Pars, Matthias Stoll, Josef Conzen, Seza Bolat, Refik Pul, Ralf-Peter Vonberg, Ludwig Sedlacek, Ulrich Wurster and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Thomas SkripuletzDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.ORCID 0000-0001-8550-335X
Philipp SchwenkenbecherDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.
Kaweh ParsDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.ORCID 0000-0002-1600-4263
Matthias StollDepartment of Immunology and Rheumatology, Hannover Medical School, 30625 Hannover, Germany.
Josef ConzenDepartment of Diagnostic and Interventional Neuroradiology, Hannover Medical School, 30625 Hannover, Germany.
Seza BolatDepartment of Neurology, University of Lübeck, 23538 Lübeck, Germany.
Refik PulDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.ORCID 0000-0002-0577-5206
Ralf-Peter VonbergInstitute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, 30625 Hannover, Germany.
Ludwig SedlacekInstitute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0001-9715-7255
Ulrich WursterDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.
Martin StangelDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.ORCID 0000-0003-2504-5398
Corinna TrebstDepartment of Neurology, Hannover Medical School, Carl-Neuberg-Straße-1, 30625 Hanover, Germany.
Medizinische Hochschule Hannover · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptococcal meningoencephalitis represents a serious infection of the central nervous system, where reliable prognostic factors during the disease course are needed. Twenty-one patients diagnosed with cryptococcal meningoencephalitis in a German university hospital from 1999 to 2013 were analysed retrospectively. CSF parameters were analysed prior to therapy and during antifungal treatment and were compared between patients who survived or deceased. Fifteen patients clinically improved after antifungal therapy, while six patients died. No differences were observed between the outcome groups for the CSF parameters cell count, lactate, total protein, and CSF-serum albumin quotients (QAlb). Follow-up examinations of serum cryptococcal antigen titer and CSF cell count have shown that these parameters cannot be used to monitor the efficacy of antifungal therapy as well. In contrast, the course of QAlb during therapy was indicative for the outcome as a possible prognostic marker. In patients with clinical improvement QAlb values were falling under therapy, while rising QAlb values were found in patients with fatal outcome indicating a continuing dysfunction of the blood-CSF barrier. In conclusion, our results indicate that, among the various CSF parameters, the course of QAlb presents a promising marker that might be used to monitor the efficacy of antifungal therapy.

Indexed as

AdultHumansMeningitis, CryptococcalMeningoencephalitisMiddle Aged

Identifiers

PMID25374433
PMCPMC4211327
OpenAlexW1969298067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.